L Brands Reports Record Fourth Quarter and Full-Year Earnings
Feb 24, 2016 21:30 pm UTC| Business
COLUMBUS, Ohio, Feb. 24, 2016 -- L Brands, Inc. (NYSE:LB) today reported record 2015 fourth quarter and full-year results. Leslie H. Wexner, chairman and chief executive officer, commented, “We delivered record...
LYDALL Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2015
Feb 24, 2016 21:30 pm UTC| Business
Q4 2015 adjusted EPS of $0.46, up 39% from adjusted Q4 2014 EPS2015 adjusted EPS of $2.10, a company record, up 21% from 2014 adjusted EPSOrganic sales growth of 6.7% in Q4 2015; 3.0% in 20152015 adjusted operating margin...
AMERISAFE Announces 2015 Fourth Quarter and Year-End Results
Feb 24, 2016 21:30 pm UTC| Business
2015 Net Income Grows 31.3%Increases Regular Dividend 20.0% DERIDDER, La., Feb. 24, 2016 -- AMERISAFE, Inc. (Nasdaq:AMSF), a specialty provider of hazardous workers’ compensation insurance, today announced results for...
Churchill Downs Incorporated Reports 2015 Fourth Quarter and Full Year Results
Feb 24, 2016 21:30 pm UTC| Business
LOUISVILLE, Ky., Feb. 24, 2016 -- Churchill Downs Incorporated (NASDAQ:CHDN) (CDI or Company) today reported business results for the quarter and full year ended December 31, 2015. Full Year 2015 Highlights Generated...
Feb 24, 2016 21:28 pm UTC| Business
HANOVER, Md., Feb. 24, 2016 -- The KEYW Corporation, a wholly-owned subsidiary of The KEYW Holding Corporation (NASDAQ:KEYW), announced today it has signed a definitive agreement to sell its systems engineering and...
Southwest Georgia Financial Corporation Declares Quarterly Cash Dividend
Feb 24, 2016 21:27 pm UTC| Business
MOULTRIE, Ga., Feb. 24, 2016 -- Southwest Georgia Financial Corporation (NYSE MKT:SGB), the parent company of Southwest Georgia Bank, announced that its Board of Directors has declared a quarterly cash dividend of $0.10...
Prothena Announces Appointment of Chief Commercial Officer
Feb 24, 2016 21:22 pm UTC| Business
DUBLIN, Ireland, Feb. 24, 2016 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies,...